🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
This trial is conducted in China. The aim of the trial is to evaluate the e...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-11-29
Trial ID
NCT06716216
This is a 24 week study comparing the efficacy of four dose levels of INT13...
Status
Completed
Location
Northern California Research
Start Date
2008-02
Trial ID
NCT00631007
Treatments Being Tested
There are recent advances in therapies for the treatment of Type 2 Diabetes...
Status
Completed
Location
University Hospitals of Leicester NHS Trust, Diabetes Research Centre
Start Date
2013-12-16
Trial ID
NCT02043054
Treatments Being Tested
The goal of this clinical trial is to compare blood-sugar control and blood...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08
Trial ID
NCT05688332
Treatments Being Tested
Metabolic defects contributing to the development of type 2 diabetes (T2D) ...
Status
Completed
Location
Diabetes Research Institute
Start Date
2008-04
Trial ID
NCT01156597
Treatments Being Tested
The aim of this study is to evaluate whether exposure to semaglutide influe...
Status
Completed
Location
University of Southern Denmark
Start Date
2021-01-26
Trial ID
NCT04572165
Treatments Being Tested
The purpose of the study is to assess the effect of the addition of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02532855
The purpose of this investigational study is to determine the safety and ef...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00094770
Treatments Being Tested
In studies of Exubera in persons with diabetes, lung cancer occurred in a f...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-08
Trial ID
NCT00734591
Treatments Being Tested